{"id":"https://openalex.org/W4415474186","doi":"https://doi.org/10.1681/asn.20258dpdyytc","title":"Discovery of Off-Target Effects of SGLT2 Inhibitors","display_name":"Discovery of Off-Target Effects of SGLT2 Inhibitors","publication_year":2025,"publication_date":"2025-10-01","ids":{"openalex":"https://openalex.org/W4415474186","doi":"https://doi.org/10.1681/asn.20258dpdyytc"},"language":"en","primary_location":{"id":"doi:10.1681/asn.20258dpdyytc","doi":"https://doi.org/10.1681/asn.20258dpdyytc","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20258dpdyytc","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083069127","display_name":"Anja M. Billing","orcid":"https://orcid.org/0000-0002-5770-5496","observed_orcids":["https://orcid.org/0000-0002-5770-5496"]},"institutions":[{"id":"https://openalex.org/I204337017","display_name":"Aarhus University","ror":"https://ror.org/01aj84f44","country_code":"DK","type":"education","lineage":["https://openalex.org/I204337017"]},{"id":"https://openalex.org/I4210115617","display_name":"Central Denmark Region","ror":"https://ror.org/0247ay475","country_code":"DK","type":"government","lineage":["https://openalex.org/I4210115617"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Anja M. Billing","raw_affiliation_strings":["Aarhus Universitet, Aarhus, Central Denmark Region , Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aarhus Universitet, Aarhus, Central Denmark Region , Denmark;","institution_ids":["https://openalex.org/I204337017","https://openalex.org/I4210115617"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111102147","display_name":"Elina Kovalenko","orcid":"https://orcid.org/0009-0003-0991-6672","observed_orcids":["https://orcid.org/0009-0003-0991-6672"]},"institutions":[{"id":"https://openalex.org/I204337017","display_name":"Aarhus University","ror":"https://ror.org/01aj84f44","country_code":"DK","type":"education","lineage":["https://openalex.org/I204337017"]},{"id":"https://openalex.org/I4210115617","display_name":"Central Denmark Region","ror":"https://ror.org/0247ay475","country_code":"DK","type":"government","lineage":["https://openalex.org/I4210115617"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Elina Kovalenko","raw_affiliation_strings":["Aarhus Universitet, Aarhus, Central Denmark Region , Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aarhus Universitet, Aarhus, Central Denmark Region , Denmark;","institution_ids":["https://openalex.org/I204337017","https://openalex.org/I4210115617"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100682974","display_name":"Young Chul Kim","orcid":"https://orcid.org/0000-0002-6782-2186","observed_orcids":["https://orcid.org/0000-0002-6782-2186"]},"institutions":[{"id":"https://openalex.org/I160856358","display_name":"University of San Diego","ror":"https://ror.org/03jbbze48","country_code":"US","type":"education","lineage":["https://openalex.org/I160856358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Young Chul Kim","raw_affiliation_strings":["University of San Diego, San Diego, California, United States;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of San Diego, San Diego, California, United States;","institution_ids":["https://openalex.org/I160856358"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034859848","display_name":"Vera Christine Wulfmeyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204337017","display_name":"Aarhus University","ror":"https://ror.org/01aj84f44","country_code":"DK","type":"education","lineage":["https://openalex.org/I204337017"]},{"id":"https://openalex.org/I4210115617","display_name":"Central Denmark Region","ror":"https://ror.org/0247ay475","country_code":"DK","type":"government","lineage":["https://openalex.org/I4210115617"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Vera Christine Wulfmeyer","raw_affiliation_strings":["Aarhus Universitet, Aarhus, Central Denmark Region , Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aarhus Universitet, Aarhus, Central Denmark Region , Denmark;","institution_ids":["https://openalex.org/I204337017","https://openalex.org/I4210115617"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085734264","display_name":"Volker Vallon","orcid":"https://orcid.org/0000-0002-9211-2063","observed_orcids":["https://orcid.org/0000-0002-9211-2063"]},"institutions":[{"id":"https://openalex.org/I160856358","display_name":"University of San Diego","ror":"https://ror.org/03jbbze48","country_code":"US","type":"education","lineage":["https://openalex.org/I160856358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Volker Vallon","raw_affiliation_strings":["University of San Diego, San Diego, California, United States;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of San Diego, San Diego, California, United States;","institution_ids":["https://openalex.org/I160856358"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042034514","display_name":"Markus Matthias Rinschen","orcid":"https://orcid.org/0000-0002-9252-1342","observed_orcids":["https://orcid.org/0000-0002-9252-1342"]},"institutions":[{"id":"https://openalex.org/I204337017","display_name":"Aarhus University","ror":"https://ror.org/01aj84f44","country_code":"DK","type":"education","lineage":["https://openalex.org/I204337017"]},{"id":"https://openalex.org/I4210108711","display_name":"University Medical Center Hamburg-Eppendorf","ror":"https://ror.org/01zgy1s35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I159176309","https://openalex.org/I4210108711"]},{"id":"https://openalex.org/I4210115617","display_name":"Central Denmark Region","ror":"https://ror.org/0247ay475","country_code":"DK","type":"government","lineage":["https://openalex.org/I4210115617"]}],"countries":["DE","DK"],"is_corresponding":false,"raw_author_name":"Markus M. Rinschen","raw_affiliation_strings":["Aarhus Universitet, Aarhus, Central Denmark Region , Denmark;","Universitatsklinikum Hamburg-Eppendorf, Hamburg, HH, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aarhus Universitet, Aarhus, Central Denmark Region , Denmark;","institution_ids":["https://openalex.org/I204337017","https://openalex.org/I4210115617"]},{"raw_affiliation_string":"Universitatsklinikum Hamburg-Eppendorf, Hamburg, HH, Germany","institution_ids":["https://openalex.org/I4210108711"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.3375573,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"10S","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5601000189781189,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5601000189781189,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.07769999653100967,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.06120000034570694,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":1.0},{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.9399999976158142},{"id":"https://openalex.org/keywords/off-target-effects","display_name":"off-target effects","score":0.9919999837875366},{"id":"https://openalex.org/keywords/solute-carriers","display_name":"solute carrier transporters","score":0.7860000133514404},{"id":"https://openalex.org/keywords/slc17a1","display_name":"SLC17A1","score":0.9480000138282776},{"id":"https://openalex.org/keywords/slc31a1","display_name":"SLC31A1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/slc5a2","display_name":"SLC5A2","score":0.8659999966621399},{"id":"https://openalex.org/keywords/uremic-toxins","display_name":"uremic toxins","score":0.8420000076293945},{"id":"https://openalex.org/keywords/cardioprotection","display_name":"cardioprotection","score":0.6549999713897705},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.7990000247955322},{"id":"https://openalex.org/keywords/akita-mice","display_name":"Akita mice","score":0.6259999871253967}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4375},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42590001225471497},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37779998779296875},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.33399999141693115},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.31439998745918274},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.3124000132083893},{"id":"https://openalex.org/C2779922275","wikidata":"https://www.wikidata.org/wiki/Q1129105","display_name":"Diabetic nephropathy","level":3,"score":0.2865999937057495},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.26170000433921814},{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.2492000013589859},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.24660000205039978}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1681/asn.20258dpdyytc","doi":"https://doi.org/10.1681/asn.20258dpdyytc","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20258dpdyytc","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4397041012","https://openalex.org/W4389117640","https://openalex.org/W4378674858","https://openalex.org/W4225368729","https://openalex.org/W4390344707","https://openalex.org/W7203930364","https://openalex.org/W7164415172","https://openalex.org/W4281285719","https://openalex.org/W4403831053","https://openalex.org/W4389289227"],"abstract_inverted_index":{"Background:":[0],"SGLT2":[1,64,244],"inhibitors":[2],"(SGLT2i),":[3],"initially":[4],"developed":[5],"for":[6],"hyperglycemia":[7],"management,":[8],"have":[9],"shown":[10],"protective":[11],"effects":[12,28],"against":[13],"renal":[14,43],"and":[15,32,60,67,74,106,139,142,172,203,209],"cardiovascular":[16,231],"complications,":[17],"regardless":[18],"of":[19,51,127,134,155,166,169,184,221,243],"diabetes":[20],"status.":[21],"However,":[22],"the":[23,128,182,190,224,239],"molecular":[24,241],"mechanisms":[25],"behind":[26],"these":[27,197],"remain":[29],"largely":[30],"unknown":[31],"cannot":[33],"be":[34],"fully":[35],"explained":[36],"by":[37,163,176],"their":[38],"primary":[39,191],"role":[40],"in":[41,63,83,137,206,223],"inhibiting":[42],"glucose":[44],"reabsorption.":[45],"Methods:":[46],"To":[47,195],"explore":[48],"potential":[49,219],"off-targets":[50,220],"SGLT2i,":[52],"we":[53,199],"used":[54],"LC-MS/MS":[55],"to":[56,118,153,230],"assess":[57],"drug-induced":[58],"proteomic":[59],"metabolomic":[61],"changes":[62],"knockout":[65],"(SGLT2KO)":[66],"wildtype":[68],"(SGLT2WT)":[69],"mice,":[70],"both":[71],"diabetic":[72,141],"(Akita)":[73],"non-diabetic.":[75],"Protein-drug":[76],"interactions":[77],"were":[78,161,174],"also":[79],"examined":[80],"ex":[81],"vivo":[82],"kidney":[84,129],"tissue":[85],"via":[86],"thermal":[87],"proteome":[88],"profiling":[89,126],"(TPP).":[90],"Proteomic":[91,125],"analysis":[92],"was":[93,111],"conducted":[94],"label-free":[95],"or":[96],"with":[97],"TMT-16-plex":[98],"labeling":[99],"using":[100,113,212],"an":[101,119],"Exploris":[102],"480":[103],"mass":[104],"spectrometer":[105],"UltiMate3000":[107],"RSLC.":[108],"Targeted":[109],"metabolomics":[110],"performed":[112],"a":[114],"6495C":[115],"triple-quadrupole":[116],"coupled":[117],"Agilent":[120],"1290":[121],"Infinity":[122],"HPLC.":[123],"Results:":[124],"cortex":[130],"after":[131],"12":[132],"weeks":[133],"dapagliflozin":[135,164],"treatment":[136],"SGLT2KO":[138],"SGLT2WT":[140],"non-diabetic":[143],"mice":[144],"revealed":[145],"clear":[146],"off-target":[147],"effects.":[148],"Functional":[149],"enrichment":[150],"analyses":[151],"point":[152],"modulation":[154],"solute":[156,186],"carrier":[157],"transmembrane":[158],"transporters,":[159],"which":[160,226],"induced":[162],"independently":[165],"SGLT2.":[167],"Two":[168],"them,":[170],"SLC17A1":[171],"SLC31A1,":[173],"validated":[175],"Westernblotting.":[177],"Similarly,":[178],"TPP":[179],"data":[180],"suggested":[181],"involvement":[183],"other":[185],"carriers":[187],"(SLCs)":[188],"beyond":[189],"target,":[192],"SLC5A2":[193],"(SGLT2).":[194],"confirm":[196],"findings,":[198],"measured":[200],"uremic":[201],"toxins":[202],"SLC-transported":[204],"metabolites":[205],"corresponding":[207],"serum":[208],"urine":[210],"samples":[211],"targeted":[213],"metabolomics.":[214],"Conclusion:":[215],"Our":[216],"study":[217],"identified":[218],"SGLT2i":[222],"kidney,":[225],"may":[227],"indirectly":[228],"contribute":[229],"protection.":[232],"These":[233],"findings":[234],"provide":[235],"new":[236],"insights":[237],"into":[238],"broader":[240],"actions":[242],"inhibitors.":[245]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-23T00:00:00"}